229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-14.49%
Negative revenue growth while VUZI stands at 126.82%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-16.80%
Negative gross profit growth while VUZI is at 824.83%. Joel Greenblatt would examine cost competitiveness or demand decline.
-22.95%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-22.95%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-21.31%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-20.34%
Negative EPS growth while VUZI is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-20.69%
Negative diluted EPS growth while VUZI is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-1.10%
Share reduction while VUZI is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.06%
Reduced diluted shares while VUZI is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
12.54%
Dividend growth of 12.54% while VUZI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-21.45%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-22.32%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
1303.27%
Positive 10Y revenue/share CAGR while VUZI is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
252.10%
Positive 5Y CAGR while VUZI is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
62.06%
Positive 3Y CAGR while VUZI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
3061.99%
10Y OCF/share CAGR above 1.5x VUZI's 63.03%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
247.90%
Positive OCF/share growth while VUZI is negative. John Neff might see a comparative advantage in operational cash viability.
68.31%
3Y OCF/share CAGR above 1.5x VUZI's 33.92%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
3232.86%
Net income/share CAGR above 1.5x VUZI's 66.33% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
265.77%
5Y net income/share CAGR above 1.5x VUZI's 54.94%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
38.45%
3Y net income/share CAGR 50-75% of VUZI's 55.06%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
1734.71%
10Y equity/share CAGR above 1.5x VUZI's 309.75%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
224.87%
5Y equity/share CAGR 1.25-1.5x VUZI's 201.35%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
28.69%
Below 50% of VUZI's 187.92%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.91%
Firm’s AR is declining while VUZI shows 687.59%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-14.77%
Inventory is declining while VUZI stands at 62.11%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
4.58%
Positive asset growth while VUZI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-1.49%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
24.04%
Debt growth far above VUZI's 8.71%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
6.05%
R&D dropping or stable vs. VUZI's 28.93%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
3.01%
SG&A declining or stable vs. VUZI's 16.22%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.
